Analysis on the correlation between number of lymph nodes examined and prognosis in patients with stage II colorectal cancer

被引:0
|
作者
Zhang Xingmao
Wang Hongying
Zhou Zhixiang
Wang Zheng
机构
[1] Chinese Academy of Medical Sciences,Department of Gastrointestinal Cancer Surgery, Cancer Hospital
[2] Peking Union Medical College,State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital
[3] Chinese Academy of Medical Sciences,undefined
[4] Peking Union Medical College,undefined
来源
Medical Oncology | 2013年 / 30卷
关键词
Colorectal cancer; Stage II; Lymph node; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
Lymph nodes examined is important for N staging of colorectal cancer. There is no consensus on the optimal minimum number of lymph nodes for stage II colorectal cancer. This study was designed to determine the minimum number of lymph nodes and to identify the correlation between prognosis of stage II colorectal cancer and number of lymph nodes examined. Data of 729 patients with stage II colorectal cancer who underwent radical resection were studied retrospectively. The mean number of lymph nodes was 14.9 (range 1–58). Five-year survival rate was 76.8 %, and an average of 10.9 nodes was examined from deaths and 15.7 from survivors (P = 0.000). The difference of survival rates between patients with 13 or more nodes and less than 13 nodes was the most obvious (88.7 vs 64.9 %, P = 0.000). Thirteen was recommended as the minimum number of lymph nodes according to our results.
引用
收藏
相关论文
共 50 条
  • [1] Analysis on the correlation between number of lymph nodes examined and prognosis in patients with stage II colorectal cancer
    Zhang Xingmao
    Wang Hongying
    Zhou Zhixiang
    Wang Zheng
    [J]. MEDICAL ONCOLOGY, 2013, 30 (01)
  • [2] Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer
    Sarli, L
    Bader, G
    Iusco, D
    Salvemini, C
    Di Mauro, D
    Mazzeo, A
    Regina, G
    Roncoroni, L
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (02) : 272 - 279
  • [3] Size and number of examined lymph nodes impacts outcome in patients with stage II colorectal cancer.
    Chirieac, L
    Suehiro, Y
    Niemisto, A
    Shmulevich, I
    Lunagomez, S
    Morris, J
    Hamilton, SR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 246S - 246S
  • [4] The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes
    Choi, Hok Kwok
    Law, Wai Lun
    Poon, Jensen T. C.
    [J]. BMC CANCER, 2010, 10
  • [5] The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes
    Hok Kwok Choi
    Wai Lun Law
    Jensen TC Poon
    [J]. BMC Cancer, 10
  • [6] The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery
    Jeon, Jeongseok
    Shen, Lingjie
    Kim, Yitak
    Kim, Hyunwook
    van Gestel, Anna J.
    Han, Yoon Dae
    Han, Dai Hoon
    You, Seng Chan
    Ahn, Joong
    Shin, Sangjoon
    Geleijnse, Gijs
    Kim, Han Sang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] THE NUMBER OF LYMPH NODES EXAMINED IS A PROGNOSTIC FACTOR FOR SURVIVAL OF PATIENTS WITH COLON CANCER STAGE II
    Inostroza, Gonzalo
    Moisan, Fabrizio
    Molina, Maria Elena
    Urrejola, Gonzalo
    Caselli, Gino
    Zutniga, Alvaro
    Pinedo, George
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
  • [8] Prognostic Impact of the Number of Examined Lymph Nodes in Stage II Colorectal Adenocarcinoma: A Retrospective Study
    Lei, Purun
    Ruan, Ying
    Liu, Jianpei
    Zhang, Qixian
    Tang, Xiao
    Wu, Juekun
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [9] Impact of Inadequate Number of Lymph Nodes Examined on Survival in Stage II Colon Cancer
    Wu, Qi
    Zhang, Zhiyuan
    Chen, Yijiao
    Chang, Jiang
    Jiang, Yudong
    Zhu, Dexiang
    Wei, Ye
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Comparison of prognostic significant number of examined lymph node between stage I and II in colorectal cancer patients.
    Oh, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 291S - 291S